Pfizer Acquires NextWave Pharmaceuticals for $680,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2336082a-6523-4773-a419-c1e87ddef876&Preview=1 -
Date
10/22/2012 -
Company Name
NextWave Pharmaceuticals -
Mailing Address
20450 Stevens Creek Boulevard Cupertino, CA 95014 -
Company Description
By listening to the needs of parents and children, and working closely with the pediatric community, including pediatricians, physician assistants and nurse practitioners, NextWave Pharmaceuticals is developing a broad line of products across several therapeutic areas. With an unwavering focus on leveraging the next wave of technologies for pediatrics, we will be able to provide unique products that address many of the compliance, convenience, dosing and safety issues children and their parents face today. -
Website
http://www.nextwavepharma.com -
Transaction Type
M&A -
Transaction Amount
$680,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Under the terms of the agreement, Pfizer will make a payment to of $255 million to NextWave’s shareholders at the closing of the transaction, and NextWave’s shareholders are eligible to receive additional payments of up to $425 million based on certain sales milestones.
